Source:http://linkedlifedata.com/resource/pubmed/id/19382595
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2009-4-22
|
pubmed:abstractText |
According to the recent data lung cancer in Czech republic is the most common malignancy in men (incidence 93/100 000) and is the leading cause of cancer death in men (mortality 90/100 000). In women is the incidence of lung cancer 30/100 000. Non-small-cell lung cancer (NSCLC) accounts for 70% to 75% of all lung cancers, while small-cell lung cancer (SCLC) accounts for 25% to 30% of cases. These two types of lung cance have a different biological characteristics which leads to a different approach in the treatment of NSCLC and SCLC. The treatment of NSCLC is based on clinical stage of disease and different treatment modalities alone or in combination are used: surgery, radiotherapy, chemotherapy and recently a novel treatment strategy--targeted therapy with biologic agents.
|
pubmed:language |
cze
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0862-495X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
317-29
|
pubmed:meshHeading | |
pubmed:year |
2008
|
pubmed:articleTitle |
[Treatment of non small cell lung cancer].
|
pubmed:affiliation |
Klinika nemocí plicních a tuberkulózy LF MU a FN Brno. jskric@fnbrno.cz
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|